HALOPERIDOL vs first‐generation antipsychotics
Leaving the study early ‐ due to adverse effects (short term) · patients with schizophrenia
It is very uncertain whether haloperidol changes leaving the study early due to adverse events as a measure of… compared with first‐generation antipsychotics (very low certainty).
1 finding from 1 review
- Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders 2015 · Cochrane Headline outcomes onlyRR 1 [0.42, 2.35]16 studies · 640 participantsVery low